ATE428413T1 - Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen - Google Patents
Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzenInfo
- Publication number
- ATE428413T1 ATE428413T1 AT04803465T AT04803465T ATE428413T1 AT E428413 T1 ATE428413 T1 AT E428413T1 AT 04803465 T AT04803465 T AT 04803465T AT 04803465 T AT04803465 T AT 04803465T AT E428413 T1 ATE428413 T1 AT E428413T1
- Authority
- AT
- Austria
- Prior art keywords
- neuropathic pain
- treatment
- peptide compounds
- new use
- central neuropathic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 208000004296 neuralgia Diseases 0.000 title abstract 2
- 208000021722 neuropathic pain Diseases 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03027742A EP1537862A1 (de) | 2003-12-02 | 2003-12-02 | Neue Verwendung von Peptidverbindungen zur Behandlung von zentralen neuropathische-Schmerzen |
| US53089503P | 2003-12-22 | 2003-12-22 | |
| EP03029632 | 2003-12-22 | ||
| PCT/EP2004/013729 WO2005053667A1 (en) | 2003-12-02 | 2004-12-02 | Novel use of peptide compounds for treating central neuropathic pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE428413T1 true ATE428413T1 (de) | 2009-05-15 |
Family
ID=34657533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04803465T ATE428413T1 (de) | 2003-12-02 | 2004-12-02 | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7794987B2 (de) |
| EP (1) | EP1689378B1 (de) |
| JP (1) | JP4664924B2 (de) |
| KR (1) | KR20060111524A (de) |
| AT (1) | ATE428413T1 (de) |
| AU (1) | AU2004294714B2 (de) |
| BR (1) | BRPI0417101A (de) |
| CA (1) | CA2545543A1 (de) |
| DE (1) | DE602004020657D1 (de) |
| EA (1) | EA013590B1 (de) |
| ES (1) | ES2325995T3 (de) |
| HK (1) | HK1095749A1 (de) |
| IL (1) | IL175770A0 (de) |
| NO (1) | NO20063064L (de) |
| NZ (1) | NZ546576A (de) |
| PL (1) | PL1689378T3 (de) |
| WO (1) | WO2005053667A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1243262E (pt) | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
| DK1243263T3 (da) | 2001-03-21 | 2003-03-17 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte |
| CA2545543A1 (en) | 2003-12-02 | 2005-06-16 | Schwarz Pharma Ag | Novel use of peptide compounds for treating central neuropathic pain |
| EP1579858A1 (de) * | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von diabetishen Neuropathie |
| US20070042969A1 (en) * | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
| US20100256179A1 (en) * | 2004-03-26 | 2010-10-07 | Ucb Pharma Gmbh | Combination therapy for pain in painful diabetic neuropathy |
| AU2005232395B2 (en) * | 2004-04-16 | 2010-09-09 | Schwarz Pharma Ag | Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| EP1604655A1 (de) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von Trigeminusneuralgie |
| NZ552651A (en) * | 2004-08-27 | 2010-07-30 | Sanol Arznei Schwarz Gmbh | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| EP1642889A1 (de) * | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Verbessertes Syntheseschema für Lacosamid |
| US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
| US20070043120A1 (en) * | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| EP1754476A1 (de) * | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie |
| US7902401B2 (en) | 2006-12-14 | 2011-03-08 | Nps Pharmaceuticals, Inc. | Fluorinated compounds |
| KR20090018863A (ko) * | 2006-06-08 | 2009-02-23 | 쉬바르츠파르마에이지 | 통증성 의학적 상태를 위한 치료제 조합 |
| CN101466390B (zh) | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
| CA2651679C (en) | 2006-06-15 | 2017-01-03 | Schwarz Pharma Ag | Pharmaceutical composition with synergistic anticonvulsant effect |
| EP1873527A1 (de) * | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Verfahren zur Identifizierung von CRMP-Modulatoren |
| WO2008070994A1 (en) | 2006-12-14 | 2008-06-19 | Nps Pharmaceuticals, Inc. | Use of d-serine derivatives for the treatment of anxiety disorders |
| US20100260716A1 (en) * | 2007-10-23 | 2010-10-14 | Ucb Pharma Gmbh | Compounds for treating demyelination conditions |
| MY159790A (en) * | 2008-04-02 | 2017-01-31 | Sanofi Aventis | Highly bridged peptides from actinomadura namibiensis |
| EP2468261A1 (de) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulierung von Lacosamid |
| EA029180B1 (ru) | 2010-12-02 | 2018-02-28 | Юсб Фарма Гмбх | Лекарственная форма лакозамида для приема один раз в сутки |
| KR20210115502A (ko) | 2020-03-13 | 2021-09-27 | (주)포에버엔케이 | 기능성 펩타이드를 함유하는 경피 통증 경감 주사액 조성물 |
| KR20230042193A (ko) | 2021-09-19 | 2023-03-28 | (주)포에버엔케이 | 기능성 펩타이드를 함유하는 경피 통증 경감 주사액 조성물 |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378729A (en) | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
| US5654301A (en) | 1985-02-15 | 1997-08-05 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
| ATE98955T1 (de) | 1987-08-01 | 1994-01-15 | Takeda Chemical Industries Ltd | Alpha-ungesaettigte amine, ihre herstellung und verwendung. |
| US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| YU47834B (sr) | 1989-08-10 | 1996-01-09 | Schering Agrochemical Limited | Azolni pesticid |
| TW217417B (de) | 1991-12-04 | 1993-12-11 | Manyu Seiyaku Kk | |
| US5585358A (en) | 1993-07-06 | 1996-12-17 | Yissum Research Development Corporation Of The Hebrew University Of Jerusalem | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
| GB9504854D0 (en) | 1994-03-31 | 1995-04-26 | Zeneca Ltd | Nitrogen derivatives |
| US5760038A (en) | 1995-02-06 | 1998-06-02 | Bristol-Myers Squibb Company | Substituted biphenyl sulfonamide endothelin antagonists |
| US5849737A (en) * | 1995-04-14 | 1998-12-15 | The Regents Of The University Of California | Compositions and methods for treating pain |
| WO1997003677A1 (en) * | 1995-07-24 | 1997-02-06 | Trustees Of Boston University | Inhibition of nmda receptor activity by pregnenolone sulfate derivatives |
| DE19544687A1 (de) | 1995-11-30 | 1997-06-05 | Thomae Gmbh Dr K | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US6114390A (en) | 1995-11-30 | 2000-09-05 | Karl Thomae Gmbh | Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| US6037324A (en) | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
| GB9601724D0 (en) | 1996-01-29 | 1996-03-27 | Merck Sharp & Dohme | Therapeutic agents |
| US5773475A (en) | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
| US6277825B1 (en) | 1996-07-22 | 2001-08-21 | University Of Utah Research Foundation | Use of conantokins for treating pain |
| KR100491282B1 (ko) | 1996-07-24 | 2005-05-24 | 워너-램버트 캄파니 엘엘씨 | 통증 치료용 이소부틸가바 및 그의 유도체 |
| US6589994B1 (en) | 1996-08-30 | 2003-07-08 | Nps Pharmaceuticals, Inc. | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound |
| US6048899A (en) | 1997-03-17 | 2000-04-11 | Research Corporation Tech., Inc. | Anticonvulsant enantiomeric amino acid derivatives |
| AU7937298A (en) | 1997-07-08 | 1999-02-08 | Ono Pharmaceutical Co. Ltd. | Amino acid derivatives |
| ATE225171T1 (de) | 1997-07-15 | 2002-10-15 | Res Corp Technologies Inc | Aminosäurederivate zur behandlung von schlaganfall |
| US6737408B1 (en) | 1997-08-07 | 2004-05-18 | University Of Cincinnati | Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
| AU7696098A (en) | 1997-08-11 | 1999-03-01 | Algos Pharmaceutical Corporation | Substance p inhibitors in combination with nmda-blockers for treating pain |
| US6492553B1 (en) | 1998-01-29 | 2002-12-10 | Aventis Pharamaceuticals Inc. | Methods for preparing N-[(aliphatic or aromatic)carbonyl)]-2-aminoaetamide compounds and for cyclizing such compounds |
| US6673832B1 (en) | 1998-05-04 | 2004-01-06 | Gudarz Davar | Methods for identifying compounds for treating pain |
| GB9816228D0 (en) | 1998-07-24 | 1998-09-23 | Pfizer Ltd | Isoquinolines |
| ES2201775T3 (es) | 1998-10-09 | 2004-03-16 | Novartis Ag | Combinacion oral de lufenuron y nitenpyram contra pulgas. |
| WO2000021509A2 (en) | 1998-10-15 | 2000-04-20 | Imperial College Innovations Limited | Methods of treatment |
| CN100424079C (zh) | 1999-09-03 | 2008-10-08 | 埃科特莱茵药品有限公司 | 双磺胺 |
| SE0001373D0 (sv) | 2000-04-13 | 2000-04-13 | Karolinska Innovations Ab | NPY Y1 receptor agonists and antagonists |
| EP1160248A1 (de) | 2000-05-31 | 2001-12-05 | Pfizer Inc. | N-(Isoxazol-5-yl)-sulfonamidderivate und ihre Verwendung als Endothelin-Antagonisten |
| DK1311256T3 (da) | 2000-08-17 | 2005-11-28 | Teva Pharma | Anvendelse af derivater af valproinsyreamider og 2-valproinsyreamider til behandling eller forebyggelse af smerter og/eller hovedpinelidelser |
| DE10041478A1 (de) | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung |
| ES2294415T3 (es) | 2000-08-25 | 2008-04-01 | Research Corporation Technologies, Inc | Uso de aminoacidos anticonvulsionantes para el tratamiento de los trastornos bipolares. |
| US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
| US7112612B2 (en) | 2000-11-21 | 2006-09-26 | Ucb S.A. | N-alkylated GABA compounds, processes for their preparation and their use as medicaments |
| EG26979A (en) | 2000-12-21 | 2015-03-01 | Astrazeneca Ab | Chemical compounds |
| JP2004530647A (ja) | 2001-01-30 | 2004-10-07 | メルク エンド カムパニー インコーポレーテッド | 高眼圧治療用眼薬組成物 |
| PT1243262E (pt) | 2001-03-20 | 2006-10-31 | Sanol Arznei Schwarz Gmbh | Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica |
| DK1243263T3 (da) | 2001-03-21 | 2003-03-17 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en klasse af peptidforbindelser til behandling af allodyni eller andre forskellige typer af kronisk- eller fantomsmerte |
| WO2002076979A1 (en) | 2001-03-27 | 2002-10-03 | Actelion Pharmaceuticals Ltd | 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| ITMI20011308A1 (it) | 2001-06-21 | 2002-12-21 | Nicox Sa | Farmaci per il dolore cronico |
| FR2831820B1 (fr) | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
| AU2003243180A1 (en) | 2002-05-17 | 2003-12-12 | Xenoport, Inc. | Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| GB0213669D0 (en) | 2002-06-14 | 2002-07-24 | Astrazeneca Ab | Chemical compounds |
| PL376993A1 (pl) | 2002-11-11 | 2006-01-23 | Bayer Healthcare Ag | Pochodne fenylo- lub heteroarylo-aminoalkanów jako antagoniści receptora IP |
| US7687080B2 (en) | 2002-11-25 | 2010-03-30 | Taraxos Inc. | Treatment of neuropathy |
| US20040213842A1 (en) | 2003-01-30 | 2004-10-28 | Dynogen Pharmaceuticals, Inc. | Methods of treating gastrointestinal tract disorders using sodium channel modulators |
| US20040209960A1 (en) | 2003-01-30 | 2004-10-21 | Dynogen Pharmaceuticals, Inc. | Methods of treating lower urinary tract disorders using sodium channell modulators |
| US20040266743A1 (en) | 2003-05-09 | 2004-12-30 | Pharmacia Corporation | Combination of an aldosterone receptor antagonist and a renin inhibitor |
| CA2542064A1 (en) | 2003-10-24 | 2005-05-06 | Exelixis, Inc. | Tao kinase modulators and methods of use |
| CA2545543A1 (en) | 2003-12-02 | 2005-06-16 | Schwarz Pharma Ag | Novel use of peptide compounds for treating central neuropathic pain |
| EP1537862A1 (de) | 2003-12-02 | 2005-06-08 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von zentralen neuropathische-Schmerzen |
| EP1541138A1 (de) | 2003-12-05 | 2005-06-15 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von Status Epilepticus und ähnlicher Zustände |
| US20060009384A1 (en) | 2003-12-05 | 2006-01-12 | David Rudd | Novel use of peptide compounds for treating status epilepticus or related conditions |
| EP1579858A1 (de) | 2004-03-26 | 2005-09-28 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von diabetishen Neuropathie |
| US20070042969A1 (en) | 2004-03-26 | 2007-02-22 | Srz Properties, Inc. | Combination therapy for pain in painful diabetic neuropathy |
| US20050227961A1 (en) | 2004-04-08 | 2005-10-13 | Vela Pharmaceuticals, Inc. | Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome |
| AU2005232395B2 (en) | 2004-04-16 | 2010-09-09 | Schwarz Pharma Ag | Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| EP1604654A1 (de) | 2004-05-18 | 2005-12-14 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von Dyskynesien |
| EP1604655A1 (de) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von Trigeminusneuralgie |
| EP1604656A1 (de) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Neue Verwendung von Peptidverbindungen zur Behandlung von amyotropher Lateralsklerose (ALS) |
| US7427601B2 (en) | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
| NZ552651A (en) | 2004-08-27 | 2010-07-30 | Sanol Arznei Schwarz Gmbh | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| EP1642889A1 (de) | 2004-10-02 | 2006-04-05 | Schwarz Pharma Ag | Verbessertes Syntheseschema für Lacosamid |
| EP1688137A1 (de) | 2005-01-28 | 2006-08-09 | Schwarz Pharma Ag | SPM 927 zur Co-Therapie der Schizophrenie |
| US20060252749A1 (en) | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
| US20070043120A1 (en) | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| US20070048372A1 (en) | 2005-08-18 | 2007-03-01 | Srz Properties, Inc. | Method for treating non-inflammatory osteoarthritic pain |
| EP1754476A1 (de) | 2005-08-18 | 2007-02-21 | Schwarz Pharma Ag | Lacosamid (SPM 927) zur Behandlung von Myalgien, z.B. Fibromyalgie |
-
2004
- 2004-12-02 CA CA002545543A patent/CA2545543A1/en not_active Abandoned
- 2004-12-02 WO PCT/EP2004/013729 patent/WO2005053667A1/en active Application Filing
- 2004-12-02 PL PL04803465T patent/PL1689378T3/pl unknown
- 2004-12-02 AU AU2004294714A patent/AU2004294714B2/en not_active Ceased
- 2004-12-02 JP JP2006541902A patent/JP4664924B2/ja not_active Expired - Fee Related
- 2004-12-02 DE DE602004020657T patent/DE602004020657D1/de not_active Expired - Lifetime
- 2004-12-02 BR BRPI0417101-2A patent/BRPI0417101A/pt not_active IP Right Cessation
- 2004-12-02 NZ NZ546576A patent/NZ546576A/en unknown
- 2004-12-02 EP EP04803465A patent/EP1689378B1/de not_active Expired - Lifetime
- 2004-12-02 AT AT04803465T patent/ATE428413T1/de not_active IP Right Cessation
- 2004-12-02 EA EA200601074A patent/EA013590B1/ru not_active IP Right Cessation
- 2004-12-02 ES ES04803465T patent/ES2325995T3/es not_active Expired - Lifetime
- 2004-12-02 KR KR1020067010051A patent/KR20060111524A/ko not_active Application Discontinuation
- 2004-12-02 US US11/000,951 patent/US7794987B2/en not_active Expired - Fee Related
-
2006
- 2006-05-18 IL IL175770A patent/IL175770A0/en unknown
- 2006-06-30 NO NO20063064A patent/NO20063064L/no not_active Application Discontinuation
-
2007
- 2007-03-20 HK HK07102954.3A patent/HK1095749A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007513119A (ja) | 2007-05-24 |
| BRPI0417101A (pt) | 2007-02-06 |
| CA2545543A1 (en) | 2005-06-16 |
| US7794987B2 (en) | 2010-09-14 |
| DE602004020657D1 (de) | 2009-05-28 |
| WO2005053667A1 (en) | 2005-06-16 |
| JP4664924B2 (ja) | 2011-04-06 |
| AU2004294714B2 (en) | 2009-12-10 |
| KR20060111524A (ko) | 2006-10-27 |
| NO20063064L (no) | 2006-09-01 |
| EA013590B1 (ru) | 2010-06-30 |
| IL175770A0 (en) | 2006-09-05 |
| PL1689378T3 (pl) | 2009-09-30 |
| HK1095749A1 (en) | 2007-05-18 |
| AU2004294714A1 (en) | 2005-06-16 |
| EP1689378A1 (de) | 2006-08-16 |
| NZ546576A (en) | 2009-05-31 |
| EA200601074A1 (ru) | 2006-10-27 |
| ES2325995T3 (es) | 2009-09-28 |
| US20050209163A1 (en) | 2005-09-22 |
| EP1689378B1 (de) | 2009-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE428413T1 (de) | Neue verwendung von peptidverbindungen zur behandlung ovn zentralen neuropathischen schmerzen | |
| ATE453653T1 (de) | Platinkomplexe zur behandlung von tumoren | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| EP1534074A4 (de) | Kombinationstherapie zur behandlung von fettleibigkeit | |
| DE60325770D1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| ATE518532T1 (de) | Neue verwendung einer peptidklasse von verbindungen zur behandlung von diabetischem neuropathischem schmerz | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| ATE494884T1 (de) | Oxidative zusammensetzung zur behandlung von keratinfasern, die spezielle aminosilikone enthält | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE602005021970D1 (de) | Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen | |
| DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
| ATE493125T1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| ATE302002T1 (de) | Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit | |
| ATE312104T1 (de) | Verbindungen zur behandlung von beeinträchtigten fundischen entspannung | |
| DE60213365D1 (de) | Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen | |
| DE60223707D1 (de) | Calcium-l-threonat zur behandlung von knochenfrakturen | |
| ATE549026T1 (de) | Verwendung von pinitol zur behandlung von leberkrankheiten in säugetieren | |
| UA87117C2 (ru) | Применение пептидных соединений для лечения центральной невропатической боли | |
| DE60239864D1 (de) | Kondensierte thiophene verbindungen und deren verwendung zur behandlung von chronischen schmerzen | |
| DE60229047D1 (de) | Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit | |
| ATE354361T1 (de) | Neue verwendung von prodigiosin zur behandlung von diabetes mellitus | |
| DE60219495D1 (de) | Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten | |
| DE10193322D2 (de) | Verwendung von Protonenpumpen-Hemmern zur Behandlung von Erkrankungen des Bewegungsapparates | |
| DE60326348D1 (de) | Makrozyclen zur behandlung von krebserkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |